Sight Sciences (SGHT) Liabilities and Shareholders Equity (2020 - 2026)

Sight Sciences has reported Liabilities and Shareholders Equity for 7 years, with the latest figure at $109.7 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 15.41% year-over-year to $109.7 million; the trailing twelve-month figure through Mar 2026 stood at $463.2 million (down 18.13% YoY), and the FY2025 full-year result was $115.3 million, down 19.28% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $109.7 million, down from $115.3 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $258.6 million in Q1 2022, with the low at $109.7 million in Q1 2026.
• Average Liabilities and Shareholders Equity over 5 years is $167.5 million, with a median of $155.6 million recorded in 2024.
• Year-over-year, Liabilities and Shareholders Equity soared 358.48% in 2022 and decreased 23.96% in 2023.
• Tracing SGHT's Liabilities and Shareholders Equity over 5 years: stood at $213.1 million in 2022, then declined by 21.79% to $166.7 million in 2023, then decreased by 14.29% to $142.8 million in 2024, then decreased by 19.28% to $115.3 million in 2025, then fell by 4.86% to $109.7 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $109.7 million (Q1 2026), $115.3 million (Q4 2025), and $116.3 million (Q3 2025), per Business Quant data.

Peer Comparison